Table 2.
Spearmen's correlation coefficients and their significance (p) are shown for the baseline expression of the examined genes in relation to immunological markers at the end of one cycle of RTX treatment of RA patients (n = 16).
| Clinical and immunological indices after one cycle of RTX therapy (n = 16) | ULK1 | P21 | Caspase 3 | MMP-9 | Cathepsin K |
|---|---|---|---|---|---|
| АСPA | 0.736 p = 0.004 |
0.710 p = 0.006 |
0.600 p = 0.02 |
||
|
| |||||
| RF | 0.582 p = 0.01 |
0.616 p = 0.01 |
|||
|
| |||||
| Number of tender joints | −0.514 p = 0.04 |
||||